Skip to main content

Advertisement

SpringerLink
Log in

Alopecia Areata, Primary Sclerosing Cholangitis, and Ulcerative Colitis: Autoimmunity and Apoptosis as Common Links?

  • Case Report
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Kountouras J, Zavos C, Chatzopoulos D (2004) Immunomodulatory benefits of cyclosporine A in inflammatory bowel disease. J Cell Mol Med 8:317–328

    PubMed  CAS  Google Scholar 

  2. Snook JA, de Silva HJ, Jewell DP (1989) The association of autoimmune disorders with inflammatory bowel disease. Q J Med 72:835–840

    PubMed  CAS  Google Scholar 

  3. Tan RS (1974) Ulcerative colitis, myasthenia gravis, atypical lichen planus, alopecia areata, vitiligo. Proc R Soc Med 67:195–19

    PubMed  CAS  Google Scholar 

  4. Thompson DM, Robinson TW, Lennard-Jones J (1974) Alopecia areata, vitiligo, scleroderma and ulcerative colitis. Proc R Soc Med 67:1010–1012

    PubMed  CAS  Google Scholar 

  5. Martinez-Mir A, Zlotogorski A, Ott J, Gordon D, Christiano AM (2003) Genetic linkage studies in alopecia areata. J Invest Dermatol Symp Proc 8:199–203

    Article  Google Scholar 

  6. Treem WR, Veligati LN, Rotter JI, Targan SR, Hyams JS (1993) Ulcerative colitis and total alopecia in a mother and her son. Gastroenterology 104:1187–1191

    PubMed  CAS  Google Scholar 

  7. Christodoulou DK, Katsanos KH, Kitsanou M, Stergiopoulou C, Hatzis J, Tsianos EV (2002) Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature. Dig Liver Dis 34:781–786

    Article  PubMed  CAS  Google Scholar 

  8. Muller SA, Winkelmann RK (1963) Alopecia areata. An evaluation of 736 patients. Arch Dermatol 88:290–29

    CAS  Google Scholar 

  9. Tang L, Cao L, Bernardo O, Chen Y, Sundberg JP, Lui H, Chung S, Shapiro J (2003) Topical mechlorethamine restores autoimmune-arrested follicular activity in mice with an alopecia areata-like disease by targeting infiltrated lymphocytes. J Invest Dermatol 120:400–406

    Article  PubMed  CAS  Google Scholar 

  10. Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS (1998) Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 101:62–67

    Article  PubMed  CAS  Google Scholar 

  11. Sato-Kawamura M, Aiba S, Tagami H (2003) Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata. Arch Dermatol Res 294:536–543

    PubMed  CAS  Google Scholar 

  12. McElwee KJ, Freyschmidt-Paul P, Hoffmann R, Kissling S, Hummel S, Vitacolonna M, Zoller M (2005) Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(–) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model. J Invest Dermatol 124:947–957

    Article  PubMed  CAS  Google Scholar 

  13. Zoller M, McElwee KJ, Vitacolonna M, Hoffmann R (2004) Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients. J Autoimmun 23:241–256

    Article  PubMed  CAS  Google Scholar 

  14. Bodemer C, Peuchmaur M, Fraitaig S, Chatenoud L, Brousse N, De Prost Y (2000) Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol 114:112–116

    Article  PubMed  CAS  Google Scholar 

  15. McElwee KJ, Freyschmidt-Paul P, Zoller M, Hoffmann R (2003) Alopecia areata susceptibility in rodent models. J Invest Dermatol Symp Proc 8:182–187

    Article  Google Scholar 

  16. Christoph T, Muller-Rover S, Audring H, Tobin DJ, Hermes B, Cotsarelis G, Ruckert R, Paus R (2000) The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol 142:862–873

    Article  PubMed  CAS  Google Scholar 

  17. Gilhar A, Shalaginov R, Assy B, Serafimovich S, Kalish RS (1999) Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice. J Invest Dermatol Symp Proc 4:207–210

    CAS  Google Scholar 

  18. Benichou G, Price VH (1999) T cell repertoire in mice with alopecia areata. J Invest Dermatol Symp Proc 4:224–225

    CAS  Google Scholar 

  19. Namazi MR (2003) Nitric oxide donors as potential additions to anti-alopecia areata armamentarium. Inflamm Res 52:227–229

    PubMed  CAS  Google Scholar 

  20. Gilhar A, Landau M, Assy B, Ullmann Y, Shalaginov R, Serafimovich S, Kalish RS (2003) Transfer of alopecia areata in the human scalp graft/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response. Clin Immunol 106:181–187

    Article  PubMed  CAS  Google Scholar 

  21. Brajac I, Gruber F, Petrovecki M, Malnar-Dragojevic D (2004) Interleukin-2 receptor alpha-chain expression in patients with alopecia areata. Acta Dermatovenerol Croat 12:154–156

    PubMed  Google Scholar 

  22. Gupta AK, Ellis CN, Cooper KD, Nickoloff BJ, Ho VC, Chan LS, Hamilton TA, Tellner DC, Griffiths CE, Voorhees JJ (1990) Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis. J Am Acad Dermatol 22(2; Pt 1):242–250

    Article  PubMed  CAS  Google Scholar 

  23. Lazarous MC, Kerdel FA (2002) Topical tacrolimus Protopic. Drugs Today (Barc) 38:7–15

    Article  Google Scholar 

  24. Nunzi E, Hamerlinck F, Cormane RH (1980) Immunopathological studies on alopecia areata. Arch Dermatol Res 269:1–11

    Article  PubMed  CAS  Google Scholar 

  25. McElwee KJ, Freyschmidt-Paul P, Sundberg JP, Hoffmann R (2003) The pathogenesis of alopecia areata in rodent models. J Invest Dermatol Symp Proc 8:6–11

    Article  Google Scholar 

  26. Carroll JM, McElwee KJE, King L, Byrne MC, Sundberg JP (2002) Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans. J Invest Dermatol 119:392–402

    Article  PubMed  CAS  Google Scholar 

  27. Bo X, Broome U, Remberger M, Sumitran-Holgersson S (2001) Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis. Gut 49:131–141

    Article  PubMed  CAS  Google Scholar 

  28. Tinmouth J, Lee M, Wanless IR, Tsui FW, Inman R, Heathcote EJ (2002) Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. Liver 22:228–234

    Article  PubMed  Google Scholar 

  29. Ludwig J, Barham SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JT (1981) Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1:632–640

    Article  PubMed  CAS  Google Scholar 

  30. Whiteside TL, Lasky S, Si L, Van Thiel DH (1985) Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis. Hepatology 5:468–474

    Article  PubMed  CAS  Google Scholar 

  31. Lindor KD, Wiesner RH, LaRusso NF, Homburger HA (1987) Enhanced autoreactivity of T-lymphocytes in primary sclerosing cholangitis. Hepatology 7:884–888

    Article  PubMed  CAS  Google Scholar 

  32. Panasiuk A, Prokopowicz D, Zak J, Panasiuk B, Wysocka J (2004) Lymphocyte subpopulations in peripheral blood in primary sclerosing cholangitis. Hepatogastroenterology 51:1289–1291

    PubMed  Google Scholar 

  33. Broome U, Hultcrantz R, Lefvert AK, Yi Q (1998) Cytokine production from colonic T cells in patients with ulcerative colitis with and without primary sclerosing cholangitis. Dis Colon Rectum 41:1543–1549

    Article  PubMed  CAS  Google Scholar 

  34. Tjandra K, Le T, Swain MG (2003) Glucocorticoid receptors are downregulated in hepatic T lymphocytes in rats with experimental cholangitis. Gut 52:1363–1370

    Article  PubMed  CAS  Google Scholar 

  35. Kyokane K, Ichihara T, Horisawa M, Suzuki N, Ichihara S, Suga S, Nakao A, Morise K (1994) Successful treatment of primary sclerosing cholangitis with cyclosporine and corticosteroid. Hepatogastroenterology 41:449–452

    PubMed  CAS  Google Scholar 

  36. Van Thiel DH, Carroll P, Abu-Elmagd K, Rodriguez-Rilo H, Irish W, McMichael J, Starzl TE (1995) Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. Am J Gastroenterol 90:455–459

    PubMed  CAS  Google Scholar 

  37. Xu B, Broome U, Ericzon BG, Sumitran-Holgersson S (2002) High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6. Gut 51:120–127

    Article  PubMed  CAS  Google Scholar 

  38. Wen Z, Fiocchi C (2004) Inflammatory bowel disease: Autoimmune or immune-mediated pathogenesis? Clin Dev Immunol 11:195–204

    Article  PubMed  Google Scholar 

  39. Shanahan F, Targan S (1994) Mechanisms of tissue injury in inflammatory bowel disease. In Inflammatory bowel disease: from bench to bedside. Targan S, Shanahan F (eds). Williams & Wilkins, Baltimore, MD, pp 78–88

    Google Scholar 

  40. Groux H, Powrie F (1999) Regulatory T cells and inflammatory bowel disease. Immunol Today 20:442–445

    Article  PubMed  CAS  Google Scholar 

  41. Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182–205

    Article  PubMed  CAS  Google Scholar 

  42. Kountouras J, Kouklakis G, Zavos C, Chatzopoulos D, Moschos J, Molyvas E, Zavos N (2003) Apoptosis, inflammatory bowel disease and carcinogenesis: overview of international and Greek experiences. Can J Gastroenterol 17:249–258

    PubMed  Google Scholar 

  43. Souza HS, Tortori CJ, Castelo-Branco MT, Carvalho AT, Margallo VS, Delgado CF, Dines I, Elia CC (2005) Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways. Int J Colorectal Dis 20:277–286

    Article  PubMed  Google Scholar 

  44. Kountouras J, Zavos C, Chatzopoulos D (2005) Anti-tumor necrosis factor therapy for ulcerative colitis. Gastroenterology 129:1138–1139

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endoscopy and Motility Unit, Central Hospital, Thessaloniki, Greece

    Panagiotis Katsinelos & George Paroutoglou

  2. Department of Gastroenterology, Second Medical Clinic, Ippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

    Jannis Kountouras & Christos Zavos

  3. 8 Fanariou Street, Byzantio, 551 33, Thessaloniki, Macedonia, Greece

    Jannis Kountouras

Authors
  1. Panagiotis Katsinelos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jannis Kountouras
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. George Paroutoglou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christos Zavos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jannis Kountouras.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Katsinelos, P., Kountouras, J., Paroutoglou, G. et al. Alopecia Areata, Primary Sclerosing Cholangitis, and Ulcerative Colitis: Autoimmunity and Apoptosis as Common Links?. Dig Dis Sci 52, 1288–1292 (2007). https://doi.org/10.1007/s10620-006-9265-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9265-3

Keywords

Search

Navigation